共 50 条
- [41] Preclinical development of siRNA therapeutics for AL amyloidosis [J]. Gene Therapy, 2011, 18 : 1150 - 1156
- [42] Stabilization of amyloidogenic antibody light chains as a potential therapeutic strategy in AL amyloidosis [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E326 - E326
- [43] Occurrence of prostaglandin D synthase in urine of patients with immunoglobulin light chain amyloidosis (AL amyloidosis) [J]. PROSTAGLANDINS, 1996, 51 (04): : 291 - 291
- [44] Frequency of hereditary systemic amyloidosis masquerading as immunoglobulin light chain, AL (primary), amyloidosis. [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 39A - 39A
- [45] Regression of gastroduodenal amyloid deposits after chemotherapies in AL amyloidosis [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 202 - 202
- [46] Radio-immunodetection of amyloid deposits in patients with AL Amyloidosis? [J]. HEMATOLOGIE, 2010, 16 (03): : 187 - 188
- [47] Radio-immunodetection of amyloid deposits in patients with AL Amyloidosis [J]. HEMATOLOGIE, 2010, 16 (04): : 271 - 272
- [49] Amyloid deposits in the bone marrow in patients with AL amyloidosis. [J]. BLOOD, 2003, 102 (11) : 365B - 365B
- [50] Clonal hematopoiesis of indeterminate potential (CHIP) in patients with amyloid light chain (AL) amyloidosis [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S281 - S281